MedPath

The Effect of vaginal Bromocriptine in controlling Adenomyosis symptoms

Phase 4
Not yet recruiting
Conditions
symptomatic adenomyosis
Registration Number
ACTRN12617001122347
Lead Sponsor
ahed ezzat allam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
Female
Target Recruitment
68
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.